Colorectal cancer
47,582 new cases in France in 2023 1
What is it?
Colorectal cancer affects the colon or rectum. It is almost always an adenocarcinoma, arising from cells in the mucous membrane lining the bowel 2.
How it develops
It most often starts as a polyp, a small growth that is initially benign. Only some polyps undergo this change. The tumor then grows through the bowel wall, reaches nearby lymph nodes and may spread to the liver or lungs 2.
How long does it take to develop?
About 2 to 3 % of polyps become cancer, and this change takes more than 10 years on average 3. Once cancer has developed, the phase during which a stool test can detect it before any symptoms lasts about 2 to 5 years 4. Removing polyps can prevent cancers.
Risk factors
- Age, especially after 50
- An affected close relative, especially before age 50
- A history of polyps or inflammatory bowel disease (Crohn’s disease, ulcerative colitis)
- Hereditary syndromes (Lynch syndrome, familial adenomatous polyposis), about 5 % of cases
- Excess weight, physical inactivity, red and processed meats, alcohol, tobacco, type 2 diabetes
What helps protect you: Physical activity, a high-fiber diet 5.
Signs that should prompt a visit to your doctor
In the early stages
- Often no noticeable signs
- The screening test looks for blood that cannot be seen with the naked eye
As it progresses
- Blood in the stool
- Recent constipation or persistent diarrhea
- Abdominal pain
- An urgent need to have a bowel movement
At an advanced stage
- Depending on the organs affected, especially the liver: pain, jaundice, a swollen abdomen
Across several stages
Fatigue, loss of weight and appetite, unexplained anemia
These signs do not mean you have cancer: they may have other causes. Unsure? Talk to your doctor.
⁶Blood in the stool, recent or persistent changes in bowel habits, abdominal pain, unexplained weight loss or fatigue 3.
Detected early or at a later stage
In the United States: 34 % found at the localized stage (within the bowel wall), 37 % at the regional stage (lymph nodes), 23 % distant 7. The long polyp phase allows several years to act before cancer even develops.
5-year survival by stage
In France, 5-year net survival: 62 % in men, 65 % in women 8.
Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.
Screening in France
Yes. An at-home fecal immunochemical test every 2 years, from ages 50 to 74. Participation: 33,1 % in 2025, below the acceptable European threshold of 45 % 9.
Monitoring for people at risk
People at high risk (personal or family history, inflammatory disease, genetic predisposition) need monitoring by colonoscopy rather than a stool test 3.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.¹⁰
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.¹⁰
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.¹⁰
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.¹⁰
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.¹⁰
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.¹⁰
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.¹⁰
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.INCa, Panorama des cancers en France, 2026
- 2.American Cancer Society, What Is Colorectal Cancer?
- 3.Santé.fr / INCa, cancers du côlon : les points clés
- 4.Geurts et al., Epidemiology and Health, 2022 (duration of the detectable preclinical phase)
- 5.American Cancer Society, Colorectal Cancer Risk Factors
- 6.INCa (cancer.fr, 2023 and 2026); Assurance Maladie; Fondation A.R.CA.D
- 7.NCI SEER, Cancer Stat Facts – Colorectal Cancer (2016-2022)
- 8.Santé publique France, survie 1989-2018 – côlon et rectum
- 9.Santé publique France, participation au dépistage organisé du cancer colorectal 2024-2025
- 10.biodena.care